New publication on ALS genetics leaded by the ITALSGEN consortium: ATXN2 & C9ORF72
A new paper of the ITALSGEN and SARDINIALS consortia listing some NeuroMI members among participants. Neurobiol Aging. 2015 Dec 8. pii:…
New publication on amyotrophic lateral sclerosis
Neurodegener Dis. 2016 Jan 9. [Epub ahead of print] BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis….
Visual disturbances in patients with cerebrovascular lesion – Monza, Nov 28th, 2015
Visual disturbances in patients with cerebrovascular lesion: assesssment and rehabilitation Nov 28th, 2015; h. 09.00-17.00 San Gerardo Hospital – Monza; Conference…
NeuroMI has been accepted to be part of the Centres of Excellence within the European Alzheimer’s Disease Consortium (EADC).
I’m glad to announce that the 4th of November, during the EADC General Assembly held in Barcelona, the NeuroMI has been…
4° European Meeting on Rett syndrome @ROMA, 30/31 Oct/1 Nov 2015
brochure congresso_05
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
8TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD 2015), Barcelona, Spain
Thursday, November 5th at 4.45pm, Dr. Piazza Fabrizio will present the latest iCAβ International Network Research News at the 8TH CLINICAL TRIALS ON ALZHEIMER’S…
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
IMPRS for Brain and Behavior
International Max Planck Research School (IMPRS) for Brain and Behavior offers a competitive world-class Ph.D. training and research program. Our research…
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.
Here is the just released Frontiers of Neurology Review. In the manuscript, we gave an update of all the results of…
First National ALS symposium: Nov 12-14th, 2015 @Napoli
The first national symposium dedicated to amyotrophic lateral sclerosis (ALS) will be promoted by AISLA (the Italian association for ALS) and…
Dementias: from genotype to cognitive phenotype; 23-24th Oct, 2015; Treviso
Genetic testing has become one important issue in clinical practice with dementia patients. A correct counseling inevitably implies a deep knowledge…